Rajthanee Hospital PCL (BKK: RJH)
Thailand
· Delayed Price · Currency is THB 22.70
-0.50 (-2.16%)
Nov 22, 2024, 12:28 PM ICT
Rajthanee Hospital PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 2,744 | 2,348 | 3,365 | 3,118 | 1,855 | 1,771 | Upgrade
|
| Other Revenue | 23.8 | 27.54 | 26.15 | 24.28 | 21.97 | 27.49 | Upgrade
|
| Revenue | 2,768 | 2,375 | 3,392 | 3,142 | 1,877 | 1,798 | Upgrade
|
| Revenue Growth (YoY) | 20.47% | -29.96% | 7.94% | 67.35% | 4.40% | 12.00% | Upgrade
|
| Cost of Revenue | 1,803 | 1,618 | 1,848 | 1,684 | 1,271 | 1,213 | Upgrade
|
| Gross Profit | 964.49 | 757.68 | 1,544 | 1,458 | 606.52 | 584.88 | Upgrade
|
| Selling, General & Admin | 302.5 | 222.43 | 244.95 | 183.46 | 153.93 | 188.19 | Upgrade
|
| Operating Expenses | 302.5 | 222.43 | 244.95 | 183.46 | 153.93 | 188.19 | Upgrade
|
| Operating Income | 661.99 | 535.25 | 1,299 | 1,274 | 452.59 | 396.69 | Upgrade
|
| Interest Expense | -49.46 | -33.54 | -24.48 | -5.92 | -0.26 | -4.34 | Upgrade
|
| Interest & Investment Income | 11.51 | 17.24 | 15.04 | 2.81 | 0.93 | 4.76 | Upgrade
|
| EBT Excluding Unusual Items | 624.04 | 518.94 | 1,289 | 1,271 | 453.26 | 397.11 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | 98.74 | Upgrade
|
| Pretax Income | 624.04 | 518.94 | 1,289 | 1,271 | 453.26 | 495.84 | Upgrade
|
| Income Tax Expense | 83.18 | 103.24 | 255.8 | 254.92 | 39.64 | 99.3 | Upgrade
|
| Earnings From Continuing Operations | 540.87 | 415.7 | 1,034 | 1,016 | 413.62 | 396.54 | Upgrade
|
| Minority Interest in Earnings | 6.08 | 3.97 | -4.45 | -4.36 | -1.13 | -0.65 | Upgrade
|
| Net Income | 546.94 | 419.67 | 1,029 | 1,012 | 412.49 | 395.89 | Upgrade
|
| Net Income to Common | 546.94 | 419.67 | 1,029 | 1,012 | 412.49 | 395.89 | Upgrade
|
| Net Income Growth | 54.05% | -59.22% | 1.71% | 145.33% | 4.20% | 55.53% | Upgrade
|
| Shares Outstanding (Basic) | 300 | 300 | 299 | 300 | 300 | 300 | Upgrade
|
| Shares Outstanding (Diluted) | 300 | 300 | 299 | 300 | 300 | 300 | Upgrade
|
| Shares Change (YoY) | 0.26% | 0.19% | -0.25% | -0.02% | - | - | Upgrade
|
| EPS (Basic) | 1.82 | 1.40 | 3.44 | 3.37 | 1.37 | 1.32 | Upgrade
|
| EPS (Diluted) | 1.82 | 1.40 | 3.44 | 3.37 | 1.37 | 1.32 | Upgrade
|
| EPS Growth | 53.65% | -59.30% | 1.96% | 145.38% | 4.20% | 55.53% | Upgrade
|
| Free Cash Flow | 48.4 | 190.74 | 571.54 | 527.23 | 189.62 | 57 | Upgrade
|
| Free Cash Flow Per Share | 0.16 | 0.64 | 1.91 | 1.76 | 0.63 | 0.19 | Upgrade
|
| Dividend Per Share | 0.250 | 1.200 | 2.500 | 2.700 | 1.000 | 1.100 | Upgrade
|
| Dividend Growth | -82.76% | -52.00% | -7.41% | 170.00% | -9.09% | 57.14% | Upgrade
|
| Gross Margin | 34.85% | 31.90% | 45.52% | 46.40% | 32.31% | 32.52% | Upgrade
|
| Operating Margin | 23.92% | 22.53% | 38.30% | 40.56% | 24.11% | 22.06% | Upgrade
|
| Profit Margin | 19.76% | 17.67% | 30.35% | 32.21% | 21.97% | 22.01% | Upgrade
|
| Free Cash Flow Margin | 1.75% | 8.03% | 16.85% | 16.78% | 10.10% | 3.17% | Upgrade
|
| EBITDA | 808.9 | 680.72 | 1,463 | 1,434 | 558.35 | 483.97 | Upgrade
|
| EBITDA Margin | 29.23% | 28.66% | 43.12% | 45.63% | 29.74% | 26.91% | Upgrade
|
| D&A For EBITDA | 146.91 | 145.47 | 163.59 | 159.33 | 105.75 | 87.29 | Upgrade
|
| EBIT | 661.99 | 535.25 | 1,299 | 1,274 | 452.59 | 396.69 | Upgrade
|
| EBIT Margin | 23.92% | 22.53% | 38.30% | 40.56% | 24.11% | 22.06% | Upgrade
|
| Effective Tax Rate | 13.33% | 19.89% | 19.84% | 20.05% | 8.75% | 20.03% | Upgrade
|
| Revenue as Reported | 2,779 | 2,393 | 3,407 | 3,145 | 1,878 | 1,902 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.